Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Other Non Operating Income (2020 - 2026)

Organon (OGN) posted quarterly Other Non Operating Income of -$29.0 million for Q2 2026, down 182.86% year-over-year from $35.0 million in Q2 2025, and down 130.21% on a QoQ basis from $96.0 million in Q1 2026.

Organon (OGN) Other Non Operating Income (2020 - 2026) Analysis & Trends

Organon has reported Other Non Operating Income for 7 years, with the latest figure at -$29.0 million in Q2 2026.

  • Other Non Operating Income for Q2 2026 came in at -$29.0 million, down 182.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $163.0 million (up 8050.0% YoY), and the FY2025 annual result was $119.0 million, up 557.69% from the prior year.
  • Other Non Operating Income retreated to -$29.0 million in Q2 2026, from $96.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $96.0 million in Q1 2026 and troughed at -$134.0 million in Q4 2022.
  • A 5-year average of -$555555.6 and a median of -$6.0 million in 2024 frame the typical range for Other Non Operating Income.
  • The widest annual swing landed in 2022, when Other Non Operating Income slumped 13300.0%; it then surged 900.0% in 2026.
  • A 5-year view of Other Non Operating Income shows it stood at -$134.0 million in 2022, then jumped by 87.31% to -$17.0 million in 2023, then grew by 11.76% to -$15.0 million in 2024, then soared by 540.0% to $66.0 million in 2025, then tumbled by 143.94% to -$29.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$29.0 million in Q2 2026, $96.0 million in Q1 2026, and $66.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.00 Mn
Mar 31, 2026 96.00 Mn
Dec 31, 2025 -67.00 Mn
Sep 30, 2025 -17.00 Mn
Jun 30, 2025 35.00 Mn
Mar 31, 2025 4.00 Mn
Dec 31, 2024 -17.00 Mn
Jun 30, 2024 -6.00 Mn
Mar 31, 2024 -3.00 Mn
Dec 31, 2023 10.00 Mn
Sep 30, 2023 -14.00 Mn
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 -6.00 Mn
Dec 31, 2022 -32.00 Mn
Sep 30, 2022 -4.00 Mn
Jun 30, 2022 -7.00 Mn
Mar 31, 2022 4.00 Mn
Dec 31, 2021 -1.00 Mn
Sep 30, 2021 -3.00 Mn
Jun 30, 2021 -20.00 Mn